对XI因子缺乏的实验室和分子诊断
1Division of Medicine, Faculty of Medical Sciences, University College London, London, United Kingdom.
Seminars in thrombosis and hemostasis
|November 4, 2024
概括
十一因子 (FXI) 缺乏,一种轻微的出血障碍,比以前想象的更常见,特别是在阿什基纳兹犹太人中. 在F11基因中识别基因变异有助于预测出血风险和管理患者.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 十一因子 (FXI) 缺乏症是一种遗传性出血障碍,患病率为1:10,00020,000,在阿什基纳兹犹太人 (1:20) 等特定人群中更高.
- 临床表现通常是轻度出血,通常与创伤或手术有关,诊断经常来自偶尔延长的激活部分血栓形成时间 (aPTT).
研究的目的:
- 审查FXI缺乏症的诊断方法,强调实验室和分子分析.
- 突出基因变异识别在预测出血风险和指导临床管理中的作用.
- 讨论潜在的诊断干扰,包括新型抗凝剂和获得的FXI抑制剂.
主要方法:
- 审查用于测量FXI活性和抗原水平的实验室测定.
- 分子诊断,包括F11基因的遗传测序,以确定致病变体.
- 对与出血表型相关联的FXI水平和遗传发现的临床数据的分析.
主要成果:
- FXI缺陷的患病率高于通常引用的,在犹太人和阿拉伯人中普遍存在特定的F11基因变异.
- FXI水平可能与出血严重程度没有可靠的相关性,这表明基因分析对于风险评估至关重要.
- 获得的FXI抑制剂很少见,但可能会使诊断复杂化.
结论:
- 精确诊断FXI缺乏症依赖于功能测试,抗原水平和分子诊断的组合.
- 鉴定致病性F11基因变异为预测出血风险提供了比单独的FXI活动水平更精确的方法.
- 了解诊断干扰对于有效的患者管理至关重要.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...